A Study of LY4175408 in Participants With Advanced Cancer
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
Mersana Therapeutics
National Cancer Institute (NCI)
Jazz Pharmaceuticals
Bayer
Genmab
Fate Therapeutics
Epsilogen Ltd
IDEAYA Biosciences
Avera McKennan Hospital & University Health Center
858 Therapeutics, Inc.
Radiopharm Theranostics, Ltd
AstraZeneca
SystImmune Inc.
Terremoto Biosciences Inc.
Institut Paoli-Calmettes
Ensem Therapeutics
Eisai Inc.
PMV Pharmaceuticals, Inc
Mayo Clinic
NiKang Therapeutics, Inc.
Alterome Therapeutics, Inc.
BeOne Medicines
National Institutes of Health Clinical Center (CC)
Psyence Australia Pty Ltd
Eli Lilly and Company
Seagen Inc.
Radiopharm Theranostics, Ltd
Myeloid Therapeutics
Tizona Therapeutics, Inc
Normunity AccelCo, Inc.
NiKang Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
SystImmune Inc.
DualityBio Inc.
Daiichi Sankyo
University of Nebraska
Adela, Inc
M.D. Anderson Cancer Center
Eli Lilly and Company
Shanghai Best-Link Bioscience, LLC
Medical College of Wisconsin
Elephas
Dren Bio
Mayo Clinic
NextCure, Inc.
Tanabe Pharma America, Inc.